BITS Pilani

  • Page last updated on Monday, September 28, 2020

Research Projects

banner
Research Projects

List of projects sanctioned/recommended in 2018


Title of the project : Development of novel anti-leishmanial analogues loaded with novel nano-formulations
Funding agency: DBT (Indo-Spain)
Duration: 2 Years (2018-2020)
Amount (lakhs): 60
PI and Co-I: Dr. S. Murugesan (PI) Dr.K.V.G. Chandrasekhar (Hyd Campus,Co-PI)
Collaborating institute if any : BITS HYBD Campus, Nanovex Biotechnologies, Spain and University of Leon, Spain

Title of the project : Umbilical cord mesenchymal stem cells derived exosomes as biogenic nanocarriers of miRNA and chemotherapeutic drug for reversal of chemoresistance in breast cancer
Funding agency: DST-Nanomission
Duration: 3 years (2018-2021)
Amount (lakhs): 56.44
PI and Co-I: Dr. Anupama Mittal (PI), Dr. Swasti Tiwari (SGPGIMS) & Dr. Amrit Gupta (SGPGIMS)
Collaborating institute if any : Sanjay Gandhi Post Graduate Institute of Medical Sciences (SGPGIMS), Lucknow, U.P, India

Title of the project : Peptide-decorated pH-sensitive nano-conjugate hybrid micelles for co-delivery of temozolamide and an autophagy inducer, rapamycin, for treatment of glioblastoma multiforme
Funding agency: DBT-Nanobiotechnology
Duration: 3 years (Dec 2017-Dec 2020)
Amount (lakhs): 38.32
PI and Co-I: Dr. Deepak Chitkara (PI) Dr. Anil Gaikwad (Co-I)

Title of the project : Actively targeted nano-formulations for co-delivery of a taxane and antioxidant molecule, alpha lipoic acid, for treating breast cancer
Funding agency: DST-Rajasthan
Duration: 3 years (2018-2021)
Amount (lakhs): 11.13
PI and Co-I: Dr. Deepak Chitkara (PI)

Title of the project : Insight into dissolution mechanism of amorphous solid dispersions of macitentan
Funding agency: DBT
Duration: 2018-2019
Amount (lakhs): 8.0
PI and Co-I: Dr. Murali M Pandey (PI)

Title of the project : Design and characterization of nanoparticle based drug delivery systems of anticancer drug
Funding agency: Crenza Pharmaceuticals Pvt. Ltd., Hyderabad (Industry Sponsored Research Project )

Duration: 2018-2020
Amount (lakhs): 8.0
PI and Co-I: Dr. Murali M Pandey (PI) Dr. Gautam Singhvi (PI)

Title of the project : Development and Evaluation of Nanostructured Lipid Particles for Brain Cancer 
Funding agency: Oniosome Healthcare Pvt. Ltd, Mohali, India.
Duration: 2018-2020
Amount (lakhs): 12.75
PI and Co-I: (i) Dr. Sunil K Dubey (ii) Dr. Gautam Singhvi

Title of the project : Development and Evaluation of Nanofibrous Ocular Patch of Selected Drugs
Funding agency: Oniosome Healthcare Pvt Ltd, Mohali, India.

Duration: 2018-2020
Amount (lakhs): 12.25
PI and Co-I: (i) Dr. Sunil K Dubey (ii) Dr. Gautam Singhvi

Title of the project : Exploring the Role of Endocrine Disrupting Chemicals (EDCs) during Pregnancy and Its Relation to Antenatal and Perinatal Events
Funding agency: Indian Council of Medical Research
Duration: 2018-2021
Amount (lakhs): Total Project Cost: 66.23 BITS Share 27.36
PI and Co-I: (i) Dr. Sunil K Dubey (CO PI) (ii) Dr. Rajeev Taliyan (CO PI)

Title of the project : Quality by design (QbD) based suspension product development and process optimization.
Funding agency: Slayback Pharma, Hyderabad, India.

Duration: 2018-2020
Amount (lakhs): 8.00
PI and Co-I: (i) Dr. Gautam Singhvi (ii) Dr. Sunil K Dubey

Title of the project : Preliminary investigation, characterization and stability analysis of micelles formulation.
Funding agency: Enaltech Pharma, Mumbai, India.
Duration: 2018-2019
Amount (lakhs): 1.41
PI and Co-I: (i) Dr. Gautam Singhvi (ii) Dr. Sunil K Dubey

Title of the project : cRGD decorated lipo-polymeric nanoplexes of CRISPR/Cas9 ribonucleoprotein (RNP) for the management of retinal dystrophic conditions
Funding agency: DBT-Nano-intervention in Management of Opthalmic Diseases
Duration: Recommended
Amount (lakhs): 149.16
PI and Co-I: Dr. Deepak Chitkara (Principle Coordinator) Dr. Anupama Mittal (Co-I) Dr. Vivek Singh (Co-PI, HERF, LVPEI), Dr. Indumathi mariappan (co-I, , HERF, LVPEI), Dr. vivek Dave (co-I, , HERF, LVPEI), Dr. Debojyoti Chakraborty (Co-PI, IGIB-CSIR)
Collaborating institute if any : 1. HERF, LV Prasad Eye Institute, Hyderabad 2. IGIB-CSIR, New Delhi

Title of the project : Gel-based composite formulation containing asiaticoside and neurotensin for rapid healing of diabetic wounds.
Funding agency: ICMR
Duration: Recommended
Amount (lakhs): 29.73
PI and Co-I: Dr. Anupama Mittal (PI) & Dr. Deepak Chitkara (Co-I)

Title of the project : Development and evaluation of lipid based nanoparticles of Quinapyramine and Isometamidium chloride for treatment of trypanosomiasis in camels
Funding agency: DBT
Duration: Recommended
Amount (lakhs): 43.52
PI and Co-I: Dr. Anil Jindal (PI), Dr. Atish Paul (Co-I), Dr. Sanjay Kumar (PI)
Collaborating institute if any : National Research Centre on Camels (NRCC), Bikaner

Research Collaborations

  • GlaxoSmithKline Pharmaceuticals Ltd.
  • Dr. Reddy's Lab
  • Lupin Pharmaceuticals Inc.
  • Novartis India Ltd.
  • IPCA Labs Ltd.
  • Genpact Analysis
  • Orbees Medical.

Collaborations

  • Collaborations

  • Collaborations

Quick Links

An Institution Deemed to be University estd. vide Sec.3 of the UGC Act,1956 under notification # F.12-23/63.U-2 of Jun 18,1964

© 2020 Centre for Software Development,SDET Unit, BITS-Pilani, India.

Designed and developed by fractal | ink design studios